The Biostatistics Core provides stafisfical collaborafion and data management support for each of the SPORE projects, the Developmental Research Program projects, the Career Development Program, and the other Cores. The Biostafistics Core prepared the stafisfical plans for each of the four projects, will provide data management for each of the projects and adverse event monitoring for the clinical trials, and will prepare data summaries for manuscript preparation. The Biostatistics Core has been very active in preparing the stafistical plans for each of the four projects in this SPORE Application. Each of the projects presented in this applicafion reflects input from members of the Biostatistics Core on study design and analysis plan. These projects require a wide range of approaches and analyses. The Biostafistics Core builds upon the innovative and time-tested procedures and systems developed by Mayo Clinic, one of the largest stafisfical groups in the country whose members have collaborated on more than 13,000 clinical and basic science research studies since 1966. The Biostafistics Core has the capability to provide statistical support across different fields. Including molecular epidemiologic studies, basic science with translational, immunologic, and correlafive studies, gene microarray, clinical trials, gene and mutation discovery, and informafion management. The comprehensive nature of the Biostafisfics Core assures each SPORE invesfigator access to statistical expertise that includes collaborative development of study designs and analysis plans, state-of-the-art data analysis and Interpretation, data management resources, and abstract and manuscript preparation. The Biostafisfics Core also provides a mechanism for the management and integration of both existing and newly collected data through consistent and compatible data handling. Areas of support include database development, data form development and processing, data collecfion and entry, data archiving, quality control, and management of information relafing to the projects and cores. This Core complements and assists the efforts of the Animal Model Core and the Biospecimens and Patient Registry Core by providing superior data management and experience with fissue registries. The strengths of the Biostatistics Core are our collaboration with each of the projects and cores, the knowledge of and ability to ufilize the established research databases, the operational and statistical infrastructure already in place in the institution, and the breadth of expertise provided by Biostatistics Core personnel.
Careful data management approaches and proper data analysis methods are required to ensure that the correct conclusions are made from a research study. The Biostafistics Core will provide expertise and support to ovarian cancer researchers in the areas of study design, data management, and data analysis.
|Karami, Sara; Han, Younghun; Pande, Mala et al. (2016) Telomere structure and maintenance gene variants and risk of five cancer types. Int J Cancer 139:2655-2670|
|Clyde, Merlise A; Palmieri Weber, Rachel; Iversen, Edwin S et al. (2016) Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. Am J Epidemiol 184:579-589|
|Radecki Breitkopf, Carmen; Ridgeway, Jennifer L; Asiedu, Gladys B et al. (2016) Ovarian cancer patients' and their family members' perspectives on novel vaccine and virotherapy trials. Clin Trials 13:660-664|
|Ezewuiro, Obiageli; Grushko, Tatyana A; Kocherginsky, Masha et al. (2016) Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy. PLoS One 11:e0147145|
|Li, Zheng; Block, Matthew S; Vierkant, Robert A et al. (2016) The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins. Tumour Biol 37:13279-13286|
|Pharoah, Paul D P; Song, Honglin; Dicks, Ed et al. (2016) PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations. J Natl Cancer Inst 108:|
|(2016) Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nat Commun 7:12675|
|Karyampudi, Lavakumar; Lamichhane, Purushottam; Krempski, James et al. (2016) PD-1 Blunts the Function of Ovarian Tumor-Infiltrating Dendritic Cells by Inactivating NF-ÎºB. Cancer Res 76:239-50|
|French, Juliet D; Johnatty, Sharon E; Lu, Yi et al. (2016) Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer. Oncotarget 7:6353-68|
|Harris, Faye R; Kovtun, Irina V; Smadbeck, James et al. (2016) Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers. Sci Rep 6:29831|
Showing the most recent 10 out of 225 publications